当耐火性不是终点时:通过三级中心评估重新定义慢性咳
Sumera R Ahmad1, Vivek N Iyer1, Allison LeMahieu2
1Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN.
Mayo Clinic proceedings. Innovations, quality & outcomes
|March 11, 2026
概括
耐火性慢性咳 (RCC) 的诊断和治疗需要专业的注意. 需要进行进一步的研究,以区分无法解释的慢性咳与专门诊所的病因确诊病例.
科学领域:
- 肺部病理学 肺部病理学
- 临床医学 临床医学
背景情况:
- 耐火性慢性咳 (RCC) 是一个诊断挑战.
- 对RCC的有效管理策略对于患者的治疗结果至关重要.
研究的目的:
- 描述耐火性慢性咳诊断和管理的临床结果.
- 为了评估第三级护理慢性咳诊所的诊断产量.
主要方法:
- 在第三级保健慢性咳诊所进行前性研究.
- 成年咳患者的查> 8周.
- 招募100名有研究授权和同意的患者.
主要成果:
- 在56名患有耐火性慢性咳的患者中,有35人 (62%) 患有病因确定的咳.
- 21名 (37%) 患者被诊断患有无法解释的慢性咳.
- 专门的中心有助于区分咳的病因.
结论:
- 耐火性慢性咳需要专注的诊断方法.
- 治疗试验对于识别无法解释的慢性咳至关重要.
- 专门的慢性咳中心对于准确的诊断和管理至关重要.
相关概念视频
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
3.3K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
3.3K
01:24Chronic Obstructive Pulmonary Disease
2.9K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.9K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
4.0K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
4.0K
01:29Chronic Obstructive Pulmonary Disease-V: Management
3.3K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.3K
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
4.0K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
4.0K
01:30Chronic Obstructive Pulmonary Disease-V: Nursing Management
5.4K
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Assessment
5.4K